Literature DB >> 17599450

Serial electrocardiographic findings in women with Takotsubo cardiomyopathy.

Wataru Mitsuma1, Makoto Kodama, Masahiro Ito, Komei Tanaka, Takao Yanagawa, Noboru Ikarashi, Kanako Sugiura, Shinpei Kimura, Nobue Yagihara, Takeshi Kashimura, Koichi Fuse, Satoru Hirono, Yuji Okura, Yoshifusa Aizawa.   

Abstract

This study aimed to clarify detailed and serial electrocardiographic findings in patients with Takotsubo cardiomyopathy from onset to recovery. Nine consecutive women aged 65 to 84 years (mean 74) with Takotsubo cardiomyopathy were investigated. Standard 12-lead electrocardiograms were recorded during hospitalization and ST-segment elevation and T-wave inversion were manually measured daily in each patient. All 9 patients had 4 phases found electrocardiographically. Phase 1 was characterized by ST-segment elevation immediately after onset. Subsequently, T-wave inversion was observed from days 1 to 3 (phase 2), then inverted T waves improved transiently from days 2 to 6 (phase 3). After this phase, giant inverted T waves with QT prolongation appeared and persisted > or =2 months until recovery (phase 4). Serum creatine kinase levels were increased only at onset. Left ventricular wall motion abnormalities evaluated using echocardiography improved gradually after phase 3 in all patients. Second T-wave inversions (phase 4) were significantly deeper than those of the first one (phase 2; p <0.05). In conclusion, 4 electrocardiographic phases in patients with Takotsubo cardiomyopathy were shown. This observation may be helpful to understand the pathophysiologic process of Takotsubo cardiomyopathy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17599450     DOI: 10.1016/j.amjcard.2007.02.062

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  19 in total

Review 1.  Transient attenuation of the amplitude of the QRS complexes in the diagnosis of Takotsubo syndrome.

Authors:  John E Madias
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-09-18

Review 2.  Systematic review of the electrocardiographic changes in the takotsubo syndrome.

Authors:  A Duran-Cambra; M Sutil-Vega; M Fiol; I J Núñez-Gil; M Vila; J Sans-Roselló; J Cinca; A Sionis
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-11-04       Impact factor: 1.468

3.  Stress-induced (takotsubo) cardiomyopathy following thoracic epidural steroid injection for postherpetic neuralgia.

Authors:  Nicholas P McKernan; Bryan J Rondeau; Russell K McAllister
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-04

Review 4.  Association of prolonged QTc interval with Takotsubo cardiomyopathy: A neurocardiac syndrome inside the mystery of the insula of Reil.

Authors:  Vincenzo Marafioti; Giulia Turri; Vincenzo Carbone; Salvatore Monaco
Journal:  Clin Cardiol       Date:  2018-04-17       Impact factor: 2.882

Review 5.  Acute stress cardiomyopathy.

Authors:  Ilan S Wittstein
Journal:  Curr Heart Fail Rep       Date:  2008-06

6.  It's a trap! Clinical similarities and subtle ECG differences between takotsubo cardiomyopathy and myocardial infarction.

Authors:  Rey P Vivo; Selim R Krim; John Hodgson
Journal:  J Gen Intern Med       Date:  2008-09-04       Impact factor: 5.128

Review 7.  Takotsubo cardiomyopathy: state-of-the-art review.

Authors:  Todd A Dorfman; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2009-01-20       Impact factor: 5.952

Review 8.  Epidemiology and pathophysiology of Takotsubo syndrome.

Authors:  Yoshihiro J Akashi; Holger M Nef; Alexander R Lyon
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

9.  Takotsubo cardiomyopathy in two female patients: two case reports.

Authors:  Aj Turley; Rj Graham; Ja Hall
Journal:  Cases J       Date:  2008-11-18

Review 10.  Takotsubo Syndrome: Uncovering Myths and Misconceptions.

Authors:  Victoria L Cammann; Michael Würdinger; Jelena R Ghadri; Christian Templin
Journal:  Curr Atheroscler Rep       Date:  2021-07-16       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.